We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ARMO BioSciences

News List

Lilly Announces Agreement to Acquire ARMO BioSciences americanpharmaceuticalreview
May 18, 2018
Eli Lilly and Company and ARMO BioSciences announced a definitive agreement for Lilly to acquire ARMO for $50 per share, or approximately $1.6 billion,
Eli Lilly to buy Armo BioSciences for US$1.6B biospectrumasia
May 14, 2018
Lilly gives an offer of US$50 per share, which represents a premium of 68 percent to Armo's Wednesday close.
ARMO BioSciences Appoints Naiyer A. Rizvi, M.D. to Board of Directors americanpharmaceuticalreview
June 29, 2017
ARMO BioSciences announced the appointment of Naiyer A. Rizvi, M.D. to its Board of Directors. Dr. Rizvi is the Director of Thoracic Oncology and Co-Director of Cancer Immunotherapy in the Division of Hematology and Oncology at Columbia University Medical